Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Report 2016-2021 - Analysis, Technologies & Forecasts - Vendors: Pfizer, Lonza, Bayer - Research and Markets

Research and Markets
Posted on: 11 Oct 16

Research and Markets has announced the addition of the "High Performance Active Pharmaceutical Ingredients (HPAPI) Market Analysis: By Ingredient (Synthetic, Biological and Others By Type of Drug and By Applications With Forecast (2016-2021)" report to their offering.

The active ingredient of a pharmaceutical drug is called an active pharmaceutical ingredient. HPAPI are compounds used to treat diseases such as cancer, hormonal imbalances, respiratory disorders, among others. High performance active pharmaceutical ingredients (HPAPI) are the fastest growing segment of the active ingredient market. Advances in clinical pharmacology and oncology research are some of the main reasons driving the growth of the HPAPI market.

An increasing geriatric population across the globe coupled with lifestyle related diseases in the younger generation are factors that are causing an increase in cancer, diabetes, cardiovascular diseases, among others. In the case of cancer, current treatments methods such as chemotherapy have severe side effects as well as they affect the non cancerous cells. Favorable government regulations are also helping with development of the pipeline of efficient drugs which is further augmenting the HPAPI market.

Companies Mentioned:

  • Bristol-Myers Squibb Company
  • Novartis International AG
  • Sanofi Aventis
  • Pfizer Inc.
  • Lonza Group
  • Novasep
  • Hospira Inc.
  • BASF AG
  • Merck & Co., Inc.
  • Sigma Aldrich Corporation
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Lonza
  • Teva Pharmaceuticals Industries Ltd.

Report Structure:

1. High Performance Active Pharmaceutical Ingredients - Market Overview

2. Executive Summary

3. High Performance Active Pharmaceutical Ingredients - Market Landscape

4. High Performance Active Pharmaceutical Ingredients - Market Forces

5. High Performance Active Pharmaceutical Ingredients Market - Strategic Analysis

6. High Performance Active Pharmaceutical Ingredients Market - By Type of Ingredient

7. High Performance Active Pharmaceutical Ingredients Market - By Type of Drug

8. High Performance Active Pharmaceutical Ingredients Market - By Application

9. High Performance Active Pharmaceutical Ingredients Market - By Geography

10. High Performance Active Pharmaceutical Ingredients Market - Market Entropy

11. Company Profiles

12. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/vgtzxw/high_performance

View source version on businesswire.com: http://www.businesswire.com/news/home/20161011006583/en/

Business Wire
www.businesswire.com

Last updated on: 11/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.